澳洲幸运5官方开奖结果体彩网

Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case

Bayer AG headquarters in Leverkusen, Germany

Bloomberg / Contributor / Getty Images

Key Takeaway

  • Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged cancer risk tied to its Roundup weed killer.
  • Shares of the pharmaceuticals and crop science conglomerate fell over 6% in German trading Monday.
  • Bayer said it believed it has "strong arguments on appeal to get this verdict overturned."

Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged♒ cancer risk tied to its Roundup weed killer, sending shares of the German pharmaceutica♒l drug giant down Monday.

The verdict reached Friday by a jury in a trial in the State Court of Cobb County, Georgia, included $2 billion in punitive damages and $65 million in 澳洲幸运5官方开奖结果体彩网:compensatory damages, a Bayer spokesman confirmed. 

Shares of the pharmaceuticals and crop science conglomerate fell over 6% in German tra♈ding Monday.

Part of Roundup Legal Cases Inherited 🐎From Monsanto

Bayer has been dealing with a slew of U.S. legal cases after its takeover of Roundup weed killer manufacturer Monsanto.

The company said it disagreed with the jury's verdict, "as it conflicts with the overwhelming weight of scientific evidence and the consensus of regulatory bodies and their scientific assessments worldwide."

“We believe that we have strong arguments on appeal to get this verdict overturned and the excessive and unconstitutio𒅌nal damage༒ awards eliminated or reduced," Bayer added.

The company said damages in Roundup-related cases that reached final judgments were cut by 90% versus original jury awards.

Do you have a news tip for Investopedia reporters? Please email us at
Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.
  1. The Wall Street Journal. "."

Compare Accounts
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.

Related Articles